AIM ImmunoTech (AIM) Misses Q2 EPS by 360c

AIM ImmunoTech (NYSE: AIM) reported Q2 EPS of ($3.68), $3.60 worse than the analyst estimate of ($0.08).

For earnings history and earnings-related data on AIM ImmunoTech (AIM) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Q1 EPS miss sends shares down 9% after-hours
• Arm Holdings (ARM) PT Raised to $470 at UBS on Raised Revenue Estimates